PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 207 filers reported holding PTC THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,131,000 | +13.7% | 120,827 | 0.0% | 0.23% | -4.5% |
| Q1 2020 | $5,390,000 | +13.0% | 120,827 | +21.6% | 0.24% | +35.6% |
| Q4 2019 | $4,771,000 | -5.0% | 99,327 | -33.1% | 0.18% | -17.8% |
| Q3 2019 | $5,020,000 | -20.1% | 148,435 | +6.3% | 0.22% | -14.5% |
| Q2 2019 | $6,282,000 | +143.1% | 139,608 | +103.4% | 0.26% | +143.8% |
| Q1 2019 | $2,584,000 | +9.7% | 68,652 | 0.0% | 0.10% | +4.0% |
| Q4 2018 | $2,356,000 | +3.6% | 68,652 | +41.9% | 0.10% | +23.2% |
| Q3 2018 | $2,274,000 | +245.6% | 48,390 | +99.1% | 0.08% | +215.4% |
| Q1 2018 | $658,000 | -89.3% | 24,299 | -79.6% | 0.03% | -91.0% |
| Q4 2014 | $6,168,000 | +77.1% | 119,150 | +50.5% | 0.29% | +77.3% |
| Q3 2014 | $3,483,000 | +68.3% | 79,150 | 0.0% | 0.16% | -14.2% |
| Q2 2014 | $2,069,000 | 0.0% | 79,150 | 0.0% | 0.19% | -8.2% |
| Q1 2014 | $2,069,000 | – | 79,150 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |